Johns Hopkins Center for Bioengineering Innovation & Design

What Johns Hopkins Center for Bioengineering Innovation & Design does

The Johns Hopkins Center for Bioengineering Innovation & Design (CBID) is an academic research center within Johns Hopkins University that operates the David E. Swirnow one-year Master of Science in Bioengineering Innovation and Design program. Housed jointly between the Whiting School of Engineering and the School of Medicine, the program accepts a capped cohort of 25 students per year and has graduated more than 300 MSE students since its first class in 2009. Its pedagogy is anchored in the proprietary Spiral Innovation Model, an iterative four-theme framework (Clinical, Commercial, Technical, Organizational) that replaces the traditional linear bench-to-bedside pathway. Students complete an 8-week clinical rotation across 11 departments at Johns Hopkins Hospital, a month-long global health immersion in countries including Nepal, Kenya, Tanzania, India, and Indonesia, and an intensive medical device design capstone leading to patents, prototypes, and commercialization-stage ventures.

CBID's business model is non-profit academic in nature. Direct revenue is generated through tuition and fees (approximately $68,670 per student for tuition/fees, with total attendance costs around $105,645). Indirect revenue is sourced from foundation grants (Abell Foundation funds the second-year fellowship), federal grants (NIH via the BluePrint MedTech Program, USAID), and philanthropy (Bill & Melinda Gates Foundation, GE Foundation). The program produces no commercial products itself; instead, its outputs are alumni and ventures — 14 startups launched, 7 products currently in market, 35+ patent applications, and over $45M in alumni startup equity funding. Its customer base is three-tiered: graduate students (primary), medical device industry employers (Medtronic, J&J, Stryker, Boston Scientific, BD, Edwards Life Sciences) who recruit CBID alumni, and global health organizations that co-develop low-resource healthcare projects.

The center's strategic posture emphasizes ecosystem breadth: clinical partnerships with Johns Hopkins Hospital and Aravind Eye Hospital, software/innovation partnerships with Intelehealth and the Coulter Translational Partnership, dedicated verticals such as the Global Women's Health Innovation Program (GWHIP), and a continuous stream of student-driven competition wins and conference appearances (HopStart 2026, LSI USA 2026, Design Day 2026, Healthcare Design Competition). CBID does not pursue AI/ML as a core capability but selectively incorporates it within global health and telemedicine projects.

Name

Johns Hopkins Center for Bioengineering Innovation & Design

Legal name

The Johns Hopkins Center for Bioengineering Innovation & Design

Website

https://cbid.bme.jhu.edu

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

CBID runs Johns Hopkins University's one-year MSE in Bioengineering Innovation & Design, training capped cohorts of 25 graduate students annually in clinical immersion, global health, and medical device design, producing alumni-launched medtech startups.

Ownership category

akta.pro rank

Product category

Graduate Biomedical Engineering Education

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Medical device design
• Bioengineering education
• Healthcare innovation
• Clinical immersion training
• Global health innovation

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Pricing tiers

Distribution channels1 record

Marketing channels7 records

Core offering

CBID delivers a one-year Master of Science in Engineering (MSE) program in Bioengineering Innovation and Design that combines clinical immersion at Johns Hopkins Hospital, global health immersion in developing countries, and hands-on medical device design prototyping and commercialization. The center also offers a Second Year Fellowship (supported by the Abell Foundation) and applies its proprietary Spiral Innovation Model to advance biomedical engineering solutions.

Product overview

The Johns Hopkins Center for Bioengineering Innovation and Design (CBID) is an academic educational program, not a commercial product company. It offers a one-year Master's program in Bioengineering Innovation and Design (MSE) within Johns Hopkins University. The program does not produce or sell commercial products; rather, it facilitates student innovation projects in medical technology and global health. Student projects and startups (such as VectorCam, ARISE, Ekyaalo, Visilant, SomnOSA, and others) are independently developed by students and alumni, not CBID as an institutional product offering.

Differentiator

Problem solved

Functional benefit

Brands

• Global Women's Health Innovation Program (GWHIP): A program focused on women's health innovation initiatives.
• Spiral Innovation Model

Products and services

• David E. Swirnow Master's Program in Bioengineering Innovation and Design

Quantifiable outcome

• 14 startup companies launched from CBID projects
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered core.

• Johns Hopkins-Coulter Translational PartnershipcoreStrategic or Co-development PartnerA joint translational partnership between Johns Hopkins and the Coulter Foundation focused on moving biomedical innovations from research to clinical application. CBID is part of this broader translational effort at Johns Hopkins.
• Global Women's Health Innovation Program (GWHIP)coreStrategic or Co-development PartnerA specialized program within CBID focused on developing innovations for women's health challenges globally. Students work on projects addressing maternal health, reproductive health, and other women's health needs in both developed and developing countries.
• IntelehealthcoreStrategic or Co-development PartnerCBID collaborates with Intelehealth on AI-driven telemedicine solutions for rural India. Students have developed AI physician co-pilots and telemedicine diagnostic assistants for low-resource telemedicine settings, integrating with Intelehealth's mobile-based telehealth platform supporting local languages.
• Aravind Eye HospitalcoreStrategic or Co-development PartnerWorld's largest high-volume eye care system, based in South India, with mission of eliminating avoidable blindness. CBID students work on vision screening, telemedicine, and medical device projects in partnership with Aravind. The organization sponsors CBID projects and provides clinical expertise.
• CBID Startups (Intelehealth, Spine Align, Eyedea Medical, AssistENT, CeleFlux, and others)coreStrategic or Co-development PartnerMultiple startups have been launched through CBID including Intelehealth, Spine Align, Eyedea Medical, AssistENT, and CeleFlux. These companies often continue collaborating with CBID for ongoing innovation and talent recruitment.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Stanford Byers Center for Biodesign: The most direct peer: Stanford's flagship biodesign program trains fellows and students through clinical immersion and medical device innovation, leading to startups and patents. Both programs follow a clinical-immersion-to-design pipeline targeting medtech commercialization.
• MIT linQ Catalyst: MIT's clinical-immersive biomedical innovation program, comparable in mission to CBID: identifying unmet clinical needs, prototyping solutions, and launching ventures. Both serve as translational bridges between engineering schools and teaching hospitals.
• UCSF Rosenman Institute: A health technology innovation and entrepreneurship platform affiliated with UCSF that supports medical device and digital health founders. Shares CBID's translational focus, though oriented more toward external founders than a degree program.

Emerging players

• Duke MEDx: Duke's biomedical engineering-school-of-medicine collaboration focused on translational research and device innovation. Comparable as a cross-school health innovation hub, with less emphasis on a dedicated MSE program.
• Vanderbilt Medical Innovators Program: Vanderbilt's program trains engineering and medical students in medical device design and translational innovation. Operates at smaller scale than CBID but with overlapping clinical-immersion and prototyping curriculum.
• Georgia Tech Biomedical Engineering: One of the top-ranked U.S. BME programs with industry-aligned capstone design and translational innovation tracks. Comparable in producing medtech talent, with stronger industry co-op placement than CBID's clinical immersion model.
• Cornell MD Innovation Team (MDIT): A medical-student-led innovation program at Weill Cornell that identifies clinical needs and develops medical device prototypes. Comparable translational mission at smaller scale and focused on medical students rather than engineers.
• Caltech Medical Engineering: Caltech's medical engineering programs emphasize translational device and diagnostic innovation with deep technical specialization. Comparable R&D intensity, though smaller scale and less emphasis on the global health dimension central to CBID.
• Northwestern Center for Advanced Regenerative Engineering: Northwestern's translational bioengineering hub combining engineering and medical school resources for device and tissue innovation. Comparable cross-school structure with translational emphasis, but oriented more toward regenerative medicine.

Regional players

• Imperial College London Bioengineering Department: A leading UK bioengineering department with translational medical device research and innovation programs. Comparable academic scope, though oriented primarily toward PhD/MSc research rather than the dedicated one-year industry-facing MSE model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@JHUCBID/videos
• LinkedInlinkedin.com/company/johns-hopkins-university

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johns Hopkins Center for Bioengineering Innovation & Design